These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20841949)

  • 21. Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future.
    Kohno N
    Int J Clin Oncol; 2008 Feb; 13(1):18-23. PubMed ID: 18307015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bisphosphonates and osteonecrosis of the jaw].
    Schirmer I; Peters H; Reichart PA; Dürkop H
    Mund Kiefer Gesichtschir; 2005 Jul; 9(4):239-45. PubMed ID: 15918066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws.
    Pautke C; Bauer F; Tischer T; Kreutzer K; Weitz J; Kesting M; Hölzle F; Kolk A; Stürzenbaum SR; Wolff KD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):471-6. PubMed ID: 19231768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis.
    Raffaelli L; Scaramuzzo L; Rossi Iommetti P; Graci C; Maccauro G; Manicone PF
    J Biol Regul Homeost Agents; 2010; 24(2):115-21. PubMed ID: 20487624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
    Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
    Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
    J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
    Ardine M; Generali D; Donadio M; Bonardi S; Scoletta M; Vandone AM; Mozzati M; Bertetto O; Bottini A; Dogliotti L; Berruti A
    Ann Oncol; 2006 Aug; 17(8):1336-7. PubMed ID: 16524968
    [No Abstract]   [Full Text] [Related]  

  • 32. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases.
    Bagan JV; Murillo J; Jimenez Y; Poveda R; Milian MA; Sanchis JM; Silvestre FJ; Scully C
    J Oral Pathol Med; 2005 Feb; 34(2):120-3. PubMed ID: 15641993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
    Sanna G; Preda L; Bruschini R; Cossu Rocca M; Ferretti S; Adamoli L; Verri E; Franceschelli L; Goldhirsch A; Nolè F
    Ann Oncol; 2006 Oct; 17(10):1512-6. PubMed ID: 16936182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteonecrosis of the jaws associated with bisphosphonates: five cases].
    Woeller A; Gering A; Brix M; Bettega G; Lebeau J
    Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):417-22. PubMed ID: 17194992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.
    Bedogni A; Blandamura S; Lokmic Z; Palumbo C; Ragazzo M; Ferrari F; Tregnaghi A; Pietrogrande F; Procopio O; Saia G; Ferretti M; Bedogni G; Chiarini L; Ferronato G; Ninfo V; Lo Russo L; Lo Muzio L; Nocini PF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):358-64. PubMed ID: 18280968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.
    Kademani D; Koka S; Lacy MQ; Rajkumar SV
    Mayo Clin Proc; 2006 Aug; 81(8):1100-3. PubMed ID: 16901034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
    Williamson RA
    Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
    Nastro E; Musolino C; Allegra A; Oteri G; Cicciù M; Alonci A; Quartarone E; Alati C; De Ponte FS
    Acta Haematol; 2007; 117(3):181-7. PubMed ID: 17164581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.